Concentra Group (CON) officer disposes 3,935 shares to satisfy tax obligations

Rhea-AI Filing Summary

Concentra Group Holdings Parent, Inc. reported an insider share disposition by one of its executives. On 11/26/2025, an officer disposed of 3,935 shares of common stock at $21.04 per share, leaving 76,163 shares beneficially owned after the transaction. The filing classifies the transaction under code F, and the explanation states that the shares were withheld to satisfy tax obligations arising from the vesting of restricted stock. The reporting person serves as Executive Vice President and Chief Operating Officer, Onsite Health & Telemedicine, and the ownership is reported as held directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Rhine Michael D.

Role See Remarks

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	3,935	$21.04	$83K

Holdings After Transaction: Common Stock — 76,163 shares (Direct)

Footnotes (1)

1. [object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 12/01/2025 - 04:22 PM Learn about SEC filing dates

FAQ

What insider transaction did Concentra Group Holdings Parent, Inc. (CON) report?

The company reported that an executive officer disposed of 3,935 shares of common stock on 11/26/2025, as shown in the Form 4.

At what price were the Concentra Group (CON) shares disposed of in this Form 4?

The 3,935 shares of Concentra Group common stock were disposed of at a price of $21.04 per share.

Why were the 3,935 Concentra Group (CON) shares withheld from the executive?

The explanation states that the 3,935 shares were withheld to satisfy tax obligations arising from the vesting of restricted stock.

How many Concentra Group (CON) shares does the reporting person own after this transaction?

Following the reported transaction, the executive beneficially owns 76,163 shares of Concentra Group common stock, held directly.

What is the reporting person’s role at Concentra Group Holdings Parent, Inc. (CON)?

The reporting person is an officer, serving as Executive Vice President, Chief Operating Officer Onsite Health & Telemedicine.

Is this Concentra Group (CON) Form 4 filed by one or multiple reporting persons?

The Form 4 is indicated as filed by one reporting person, not a group filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rhine Michael D.

(Last) (First) (Middle)

C/O CONCENTRA GROUP HOLDINGS PARENT, INC

5080 SPECTRUM DRIVE, SUITE 1200W

(Street)

ADDISON TX 75001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Concentra Group Holdings Parent, Inc. [ CON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
11/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/26/2025		F(1)		3,935	D	$21.04	76,163	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares of common stock withheld to satisfy tax obligations arising out of vesting of restricted stock.

Remarks:

Executive Vice President, Chief Operating Officer Onsite Health & Telemedicine

	/s/ Timothy F. Ryan, Attorney-in-Fact	12/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.